Hypothermic oxygenated machine perfusion for extended criteria donor allografts: Preliminary experience with extended organ preservation times in the setting of organ reallocation

Background In times of critical organ shortage, poor organ pool utilization and increased use of extended‐criteria donor (ECD) allografts remain a major problem. Hypothermic oxygenated machine perfusion (HOPE) has emerged as a promising and feasible strategy in ECD liver transplantation (LT). Howeve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Artificial organs 2022-02, Vol.46 (2), p.306-311
Hauptverfasser: Pavicevic, Sandra, Uluk, Deniz, Reichelt, Sophie, Fikatas, Panagiotis, Globke, Brigitta, Raschzok, Nathanael, Schmelzle, Moritz, Öllinger, Robert, Schöning, Wenzel, Eurich, Dennis, Pratschke, Johann, Lurje, Georg
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 311
container_issue 2
container_start_page 306
container_title Artificial organs
container_volume 46
creator Pavicevic, Sandra
Uluk, Deniz
Reichelt, Sophie
Fikatas, Panagiotis
Globke, Brigitta
Raschzok, Nathanael
Schmelzle, Moritz
Öllinger, Robert
Schöning, Wenzel
Eurich, Dennis
Pratschke, Johann
Lurje, Georg
description Background In times of critical organ shortage, poor organ pool utilization and increased use of extended‐criteria donor (ECD) allografts remain a major problem. Hypothermic oxygenated machine perfusion (HOPE) has emerged as a promising and feasible strategy in ECD liver transplantation (LT). However, potential safety limits regarding the duration of perfusion are yet to be explored. Besides marginal allograft quality (steatosis), prolonged cold ischemia time remains the most important factor for a high number of liver allografts being declined for transplantation. Patients and Methods Two ECD‐allografts were each allocated to two recipients, who proved to be unsuitable to receive the assigned allograft upon arrival at the transplant center. The organs were reallocated by Eurotransplant and accepted by our center for two different backup patients. During that time, HOPE was commenced and continued until the recipient hepatectomy was completed. Postoperative allograft function was assessed by serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, and International Normalized Ratio. Incidence of early allograft dysfunction (EAD), postoperative complications, and length of hospital stay were analyzed. Results HOPE was applied for 4 h 35 min and 4 h 20 min, resulting in a total cold preservation time of 17 h 29 min and 15 h 20 min, respectively. Both recipients displayed decreasing serum transaminases and bilirubin levels postoperatively. No EAD or major postoperative complications occurred in either patient. Serum ALT and AST levels were within the normal range at discharge. Conclusions Extended HOPE enables the safe extension of preservation time for up to 18 h in human LT. End‐ischemic HOPE may significantly improve organ pool utilization, while simultaneously facilitating operating room logistics and preventing organ injury. Despite severe organ shortage, a relevant number of allografts is being declined because of marginal quality and prolonged cold ischemia time. Due to organ reallocation and operating room logistics, two extended‐criteria donor allografts were subjected to hypothermic oxygenated machine perfusion (HOPE), resulting in total cold preservation time of up to 18 h. No major complications or early allograft dysfunction occurred in either allograft. Extended HOPE might significantly improve organ pool utilization and facilitate operating room logistics.
doi_str_mv 10.1111/aor.14103
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2592316884</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2618466133</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4283-91f551c1894288718f1461d6a4bed38cd483ff755f2eca2386357516880d52863</originalsourceid><addsrcrecordid>eNp1kd9qFDEUh4Modq1e-AIS8EYvps3_yXhXilqhUBEF74Y0c7KbMpOMSabtPpcvaLa7KgjmJjnJd76E_BB6SckJrePUxHRCBSX8EVpRyWRDZSceoxWhijRSie9H6FnON4SQVhD1FB1x0TLBeLdCPy-2cywbSJO3ON5v1xBMgQFPxm58ADxDckv2MWAXE4b7AmGoxzb5AskbPMRQ9804xnUyruR3-HOC0U8-mLStfO33ECzgO182f_tjWpuA5wQZ0q0pO3_xE2Ts62IDOEMpPqxxdAc0we4O-4A-R0-cGTO8OMzH6NuH91_PL5rLq4-fzs8uGyuY5k1HnZTUUt3VUrdUOyoUHZQR1zBwbQehuXOtlI6BNYxrxWUrqdKaDJLV6hi92XvnFH8skEs_-WxhHE2AuOSeyY7xHS8q-vof9CYuKdTX9UxRLZSinFfq7Z6yKeacwPVz8lP9qJ6SfpdkX5PsH5Ks7KuDcbmeYPhD_o6uAqd74M6PsP2_qT-7-rJX_gLLhat2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2618466133</pqid></control><display><type>article</type><title>Hypothermic oxygenated machine perfusion for extended criteria donor allografts: Preliminary experience with extended organ preservation times in the setting of organ reallocation</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Pavicevic, Sandra ; Uluk, Deniz ; Reichelt, Sophie ; Fikatas, Panagiotis ; Globke, Brigitta ; Raschzok, Nathanael ; Schmelzle, Moritz ; Öllinger, Robert ; Schöning, Wenzel ; Eurich, Dennis ; Pratschke, Johann ; Lurje, Georg</creator><creatorcontrib>Pavicevic, Sandra ; Uluk, Deniz ; Reichelt, Sophie ; Fikatas, Panagiotis ; Globke, Brigitta ; Raschzok, Nathanael ; Schmelzle, Moritz ; Öllinger, Robert ; Schöning, Wenzel ; Eurich, Dennis ; Pratschke, Johann ; Lurje, Georg</creatorcontrib><description>Background In times of critical organ shortage, poor organ pool utilization and increased use of extended‐criteria donor (ECD) allografts remain a major problem. Hypothermic oxygenated machine perfusion (HOPE) has emerged as a promising and feasible strategy in ECD liver transplantation (LT). However, potential safety limits regarding the duration of perfusion are yet to be explored. Besides marginal allograft quality (steatosis), prolonged cold ischemia time remains the most important factor for a high number of liver allografts being declined for transplantation. Patients and Methods Two ECD‐allografts were each allocated to two recipients, who proved to be unsuitable to receive the assigned allograft upon arrival at the transplant center. The organs were reallocated by Eurotransplant and accepted by our center for two different backup patients. During that time, HOPE was commenced and continued until the recipient hepatectomy was completed. Postoperative allograft function was assessed by serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, and International Normalized Ratio. Incidence of early allograft dysfunction (EAD), postoperative complications, and length of hospital stay were analyzed. Results HOPE was applied for 4 h 35 min and 4 h 20 min, resulting in a total cold preservation time of 17 h 29 min and 15 h 20 min, respectively. Both recipients displayed decreasing serum transaminases and bilirubin levels postoperatively. No EAD or major postoperative complications occurred in either patient. Serum ALT and AST levels were within the normal range at discharge. Conclusions Extended HOPE enables the safe extension of preservation time for up to 18 h in human LT. End‐ischemic HOPE may significantly improve organ pool utilization, while simultaneously facilitating operating room logistics and preventing organ injury. Despite severe organ shortage, a relevant number of allografts is being declined because of marginal quality and prolonged cold ischemia time. Due to organ reallocation and operating room logistics, two extended‐criteria donor allografts were subjected to hypothermic oxygenated machine perfusion (HOPE), resulting in total cold preservation time of up to 18 h. No major complications or early allograft dysfunction occurred in either allograft. Extended HOPE might significantly improve organ pool utilization and facilitate operating room logistics.</description><identifier>ISSN: 0160-564X</identifier><identifier>EISSN: 1525-1594</identifier><identifier>DOI: 10.1111/aor.14103</identifier><identifier>PMID: 34724239</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Aged ; Alanine ; Alanine transaminase ; Alanine Transaminase - blood ; Allografts ; Aspartate aminotransferase ; Aspartate Aminotransferases - blood ; Bilirubin ; Bilirubin - blood ; Cold Ischemia ; Complications ; Criteria ; Cryopreservation ; donation after brain death ; extended criteria donor ; extended preservation time ; Female ; Hepatectomy ; Humans ; hypothermic oxygenated machine perfusion ; Injury prevention ; Ischemia ; Liver ; Liver transplantation ; Liver Transplantation - methods ; Liver transplants ; Logistics ; Male ; Middle Aged ; operating room logistics ; Organ Preservation - methods ; Oxygenation ; Patients ; Perfusion ; Perfusion - methods ; Postoperative ; Serum levels ; Steatosis ; Time Factors ; Transaminases ; Transplantation ; Transplants &amp; implants</subject><ispartof>Artificial organs, 2022-02, Vol.46 (2), p.306-311</ispartof><rights>2021 The Authors. published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC</rights><rights>2021 The Authors. Artificial Organs published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4283-91f551c1894288718f1461d6a4bed38cd483ff755f2eca2386357516880d52863</citedby><cites>FETCH-LOGICAL-c4283-91f551c1894288718f1461d6a4bed38cd483ff755f2eca2386357516880d52863</cites><orcidid>0000-0001-9674-0756</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Faor.14103$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Faor.14103$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34724239$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pavicevic, Sandra</creatorcontrib><creatorcontrib>Uluk, Deniz</creatorcontrib><creatorcontrib>Reichelt, Sophie</creatorcontrib><creatorcontrib>Fikatas, Panagiotis</creatorcontrib><creatorcontrib>Globke, Brigitta</creatorcontrib><creatorcontrib>Raschzok, Nathanael</creatorcontrib><creatorcontrib>Schmelzle, Moritz</creatorcontrib><creatorcontrib>Öllinger, Robert</creatorcontrib><creatorcontrib>Schöning, Wenzel</creatorcontrib><creatorcontrib>Eurich, Dennis</creatorcontrib><creatorcontrib>Pratschke, Johann</creatorcontrib><creatorcontrib>Lurje, Georg</creatorcontrib><title>Hypothermic oxygenated machine perfusion for extended criteria donor allografts: Preliminary experience with extended organ preservation times in the setting of organ reallocation</title><title>Artificial organs</title><addtitle>Artif Organs</addtitle><description>Background In times of critical organ shortage, poor organ pool utilization and increased use of extended‐criteria donor (ECD) allografts remain a major problem. Hypothermic oxygenated machine perfusion (HOPE) has emerged as a promising and feasible strategy in ECD liver transplantation (LT). However, potential safety limits regarding the duration of perfusion are yet to be explored. Besides marginal allograft quality (steatosis), prolonged cold ischemia time remains the most important factor for a high number of liver allografts being declined for transplantation. Patients and Methods Two ECD‐allografts were each allocated to two recipients, who proved to be unsuitable to receive the assigned allograft upon arrival at the transplant center. The organs were reallocated by Eurotransplant and accepted by our center for two different backup patients. During that time, HOPE was commenced and continued until the recipient hepatectomy was completed. Postoperative allograft function was assessed by serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, and International Normalized Ratio. Incidence of early allograft dysfunction (EAD), postoperative complications, and length of hospital stay were analyzed. Results HOPE was applied for 4 h 35 min and 4 h 20 min, resulting in a total cold preservation time of 17 h 29 min and 15 h 20 min, respectively. Both recipients displayed decreasing serum transaminases and bilirubin levels postoperatively. No EAD or major postoperative complications occurred in either patient. Serum ALT and AST levels were within the normal range at discharge. Conclusions Extended HOPE enables the safe extension of preservation time for up to 18 h in human LT. End‐ischemic HOPE may significantly improve organ pool utilization, while simultaneously facilitating operating room logistics and preventing organ injury. Despite severe organ shortage, a relevant number of allografts is being declined because of marginal quality and prolonged cold ischemia time. Due to organ reallocation and operating room logistics, two extended‐criteria donor allografts were subjected to hypothermic oxygenated machine perfusion (HOPE), resulting in total cold preservation time of up to 18 h. No major complications or early allograft dysfunction occurred in either allograft. Extended HOPE might significantly improve organ pool utilization and facilitate operating room logistics.</description><subject>Aged</subject><subject>Alanine</subject><subject>Alanine transaminase</subject><subject>Alanine Transaminase - blood</subject><subject>Allografts</subject><subject>Aspartate aminotransferase</subject><subject>Aspartate Aminotransferases - blood</subject><subject>Bilirubin</subject><subject>Bilirubin - blood</subject><subject>Cold Ischemia</subject><subject>Complications</subject><subject>Criteria</subject><subject>Cryopreservation</subject><subject>donation after brain death</subject><subject>extended criteria donor</subject><subject>extended preservation time</subject><subject>Female</subject><subject>Hepatectomy</subject><subject>Humans</subject><subject>hypothermic oxygenated machine perfusion</subject><subject>Injury prevention</subject><subject>Ischemia</subject><subject>Liver</subject><subject>Liver transplantation</subject><subject>Liver Transplantation - methods</subject><subject>Liver transplants</subject><subject>Logistics</subject><subject>Male</subject><subject>Middle Aged</subject><subject>operating room logistics</subject><subject>Organ Preservation - methods</subject><subject>Oxygenation</subject><subject>Patients</subject><subject>Perfusion</subject><subject>Perfusion - methods</subject><subject>Postoperative</subject><subject>Serum levels</subject><subject>Steatosis</subject><subject>Time Factors</subject><subject>Transaminases</subject><subject>Transplantation</subject><subject>Transplants &amp; implants</subject><issn>0160-564X</issn><issn>1525-1594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp1kd9qFDEUh4Modq1e-AIS8EYvps3_yXhXilqhUBEF74Y0c7KbMpOMSabtPpcvaLa7KgjmJjnJd76E_BB6SckJrePUxHRCBSX8EVpRyWRDZSceoxWhijRSie9H6FnON4SQVhD1FB1x0TLBeLdCPy-2cywbSJO3ON5v1xBMgQFPxm58ADxDckv2MWAXE4b7AmGoxzb5AskbPMRQ9804xnUyruR3-HOC0U8-mLStfO33ECzgO182f_tjWpuA5wQZ0q0pO3_xE2Ts62IDOEMpPqxxdAc0we4O-4A-R0-cGTO8OMzH6NuH91_PL5rLq4-fzs8uGyuY5k1HnZTUUt3VUrdUOyoUHZQR1zBwbQehuXOtlI6BNYxrxWUrqdKaDJLV6hi92XvnFH8skEs_-WxhHE2AuOSeyY7xHS8q-vof9CYuKdTX9UxRLZSinFfq7Z6yKeacwPVz8lP9qJ6SfpdkX5PsH5Ks7KuDcbmeYPhD_o6uAqd74M6PsP2_qT-7-rJX_gLLhat2</recordid><startdate>202202</startdate><enddate>202202</enddate><creator>Pavicevic, Sandra</creator><creator>Uluk, Deniz</creator><creator>Reichelt, Sophie</creator><creator>Fikatas, Panagiotis</creator><creator>Globke, Brigitta</creator><creator>Raschzok, Nathanael</creator><creator>Schmelzle, Moritz</creator><creator>Öllinger, Robert</creator><creator>Schöning, Wenzel</creator><creator>Eurich, Dennis</creator><creator>Pratschke, Johann</creator><creator>Lurje, Georg</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9674-0756</orcidid></search><sort><creationdate>202202</creationdate><title>Hypothermic oxygenated machine perfusion for extended criteria donor allografts: Preliminary experience with extended organ preservation times in the setting of organ reallocation</title><author>Pavicevic, Sandra ; Uluk, Deniz ; Reichelt, Sophie ; Fikatas, Panagiotis ; Globke, Brigitta ; Raschzok, Nathanael ; Schmelzle, Moritz ; Öllinger, Robert ; Schöning, Wenzel ; Eurich, Dennis ; Pratschke, Johann ; Lurje, Georg</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4283-91f551c1894288718f1461d6a4bed38cd483ff755f2eca2386357516880d52863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aged</topic><topic>Alanine</topic><topic>Alanine transaminase</topic><topic>Alanine Transaminase - blood</topic><topic>Allografts</topic><topic>Aspartate aminotransferase</topic><topic>Aspartate Aminotransferases - blood</topic><topic>Bilirubin</topic><topic>Bilirubin - blood</topic><topic>Cold Ischemia</topic><topic>Complications</topic><topic>Criteria</topic><topic>Cryopreservation</topic><topic>donation after brain death</topic><topic>extended criteria donor</topic><topic>extended preservation time</topic><topic>Female</topic><topic>Hepatectomy</topic><topic>Humans</topic><topic>hypothermic oxygenated machine perfusion</topic><topic>Injury prevention</topic><topic>Ischemia</topic><topic>Liver</topic><topic>Liver transplantation</topic><topic>Liver Transplantation - methods</topic><topic>Liver transplants</topic><topic>Logistics</topic><topic>Male</topic><topic>Middle Aged</topic><topic>operating room logistics</topic><topic>Organ Preservation - methods</topic><topic>Oxygenation</topic><topic>Patients</topic><topic>Perfusion</topic><topic>Perfusion - methods</topic><topic>Postoperative</topic><topic>Serum levels</topic><topic>Steatosis</topic><topic>Time Factors</topic><topic>Transaminases</topic><topic>Transplantation</topic><topic>Transplants &amp; implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pavicevic, Sandra</creatorcontrib><creatorcontrib>Uluk, Deniz</creatorcontrib><creatorcontrib>Reichelt, Sophie</creatorcontrib><creatorcontrib>Fikatas, Panagiotis</creatorcontrib><creatorcontrib>Globke, Brigitta</creatorcontrib><creatorcontrib>Raschzok, Nathanael</creatorcontrib><creatorcontrib>Schmelzle, Moritz</creatorcontrib><creatorcontrib>Öllinger, Robert</creatorcontrib><creatorcontrib>Schöning, Wenzel</creatorcontrib><creatorcontrib>Eurich, Dennis</creatorcontrib><creatorcontrib>Pratschke, Johann</creatorcontrib><creatorcontrib>Lurje, Georg</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Artificial organs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pavicevic, Sandra</au><au>Uluk, Deniz</au><au>Reichelt, Sophie</au><au>Fikatas, Panagiotis</au><au>Globke, Brigitta</au><au>Raschzok, Nathanael</au><au>Schmelzle, Moritz</au><au>Öllinger, Robert</au><au>Schöning, Wenzel</au><au>Eurich, Dennis</au><au>Pratschke, Johann</au><au>Lurje, Georg</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypothermic oxygenated machine perfusion for extended criteria donor allografts: Preliminary experience with extended organ preservation times in the setting of organ reallocation</atitle><jtitle>Artificial organs</jtitle><addtitle>Artif Organs</addtitle><date>2022-02</date><risdate>2022</risdate><volume>46</volume><issue>2</issue><spage>306</spage><epage>311</epage><pages>306-311</pages><issn>0160-564X</issn><eissn>1525-1594</eissn><abstract>Background In times of critical organ shortage, poor organ pool utilization and increased use of extended‐criteria donor (ECD) allografts remain a major problem. Hypothermic oxygenated machine perfusion (HOPE) has emerged as a promising and feasible strategy in ECD liver transplantation (LT). However, potential safety limits regarding the duration of perfusion are yet to be explored. Besides marginal allograft quality (steatosis), prolonged cold ischemia time remains the most important factor for a high number of liver allografts being declined for transplantation. Patients and Methods Two ECD‐allografts were each allocated to two recipients, who proved to be unsuitable to receive the assigned allograft upon arrival at the transplant center. The organs were reallocated by Eurotransplant and accepted by our center for two different backup patients. During that time, HOPE was commenced and continued until the recipient hepatectomy was completed. Postoperative allograft function was assessed by serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, and International Normalized Ratio. Incidence of early allograft dysfunction (EAD), postoperative complications, and length of hospital stay were analyzed. Results HOPE was applied for 4 h 35 min and 4 h 20 min, resulting in a total cold preservation time of 17 h 29 min and 15 h 20 min, respectively. Both recipients displayed decreasing serum transaminases and bilirubin levels postoperatively. No EAD or major postoperative complications occurred in either patient. Serum ALT and AST levels were within the normal range at discharge. Conclusions Extended HOPE enables the safe extension of preservation time for up to 18 h in human LT. End‐ischemic HOPE may significantly improve organ pool utilization, while simultaneously facilitating operating room logistics and preventing organ injury. Despite severe organ shortage, a relevant number of allografts is being declined because of marginal quality and prolonged cold ischemia time. Due to organ reallocation and operating room logistics, two extended‐criteria donor allografts were subjected to hypothermic oxygenated machine perfusion (HOPE), resulting in total cold preservation time of up to 18 h. No major complications or early allograft dysfunction occurred in either allograft. Extended HOPE might significantly improve organ pool utilization and facilitate operating room logistics.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34724239</pmid><doi>10.1111/aor.14103</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-9674-0756</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0160-564X
ispartof Artificial organs, 2022-02, Vol.46 (2), p.306-311
issn 0160-564X
1525-1594
language eng
recordid cdi_proquest_miscellaneous_2592316884
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Aged
Alanine
Alanine transaminase
Alanine Transaminase - blood
Allografts
Aspartate aminotransferase
Aspartate Aminotransferases - blood
Bilirubin
Bilirubin - blood
Cold Ischemia
Complications
Criteria
Cryopreservation
donation after brain death
extended criteria donor
extended preservation time
Female
Hepatectomy
Humans
hypothermic oxygenated machine perfusion
Injury prevention
Ischemia
Liver
Liver transplantation
Liver Transplantation - methods
Liver transplants
Logistics
Male
Middle Aged
operating room logistics
Organ Preservation - methods
Oxygenation
Patients
Perfusion
Perfusion - methods
Postoperative
Serum levels
Steatosis
Time Factors
Transaminases
Transplantation
Transplants & implants
title Hypothermic oxygenated machine perfusion for extended criteria donor allografts: Preliminary experience with extended organ preservation times in the setting of organ reallocation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T06%3A42%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypothermic%20oxygenated%20machine%20perfusion%20for%20extended%20criteria%20donor%20allografts:%20Preliminary%20experience%20with%20extended%20organ%20preservation%20times%20in%20the%20setting%20of%20organ%20reallocation&rft.jtitle=Artificial%20organs&rft.au=Pavicevic,%20Sandra&rft.date=2022-02&rft.volume=46&rft.issue=2&rft.spage=306&rft.epage=311&rft.pages=306-311&rft.issn=0160-564X&rft.eissn=1525-1594&rft_id=info:doi/10.1111/aor.14103&rft_dat=%3Cproquest_cross%3E2618466133%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2618466133&rft_id=info:pmid/34724239&rfr_iscdi=true